Genes Chromosomes and Cancer · 1998 · 81 citations · 29 references
Life SciencesGeneticsHematologyCancer GeneticsCytogeneticsPediatric HematologyBone Marrow PathologyClinical CytogeneticsHematologic MalignanciesMolecular CytogeneticsMyelodysplastic SyndromesChromosome 5Q LossCritical RegionCytogenetic AbnormalitiesCytogenetics In Hematologic DiseaseDeletionsMicrodeletion SyndromesMolecular Cytogenetic DiagnosisRefractory Myelodysplastic Syndrome
The 5q- syndrome is a distinct type of myelodysplastic syndrome (MDS) characterised by refractory anaemia, morphological abnormalities of megakaryocytes, and del(5q) as the sole cytogenetic abnormality. In contrast to patients with therapy-related MDS with 5q deletions, 5q- syndrome patients have a favourable prognosis and a low rate of transformation to acute leukaemia. We have previously delineated a common deleted region of 5.6 Mb between the gene for fibroblast growth factor acidic (FGF1) and the subunit of interleukin 12 (IL12B) in two patients with 5q- syndrome and small deletions, del(5)(q31q33). The present study used fluorescence in situ hybridisation (FISH) analysis of these and a third 5q- syndrome patient with a small deletion, del(5)(q33q34), to refine further the critical deleted region. This resulted in the narrowing of the common deleted region within 5q31.3-5q33 to approximately 3 Mb, flanked by the adrenergic receptor beta 2 (ADRB2) and IL/2B genes. The common region of loss in these three 5q- syndrome patients includes the macrophage colony-stimulating factor-1 receptor (CSF1R), secreted protein, acidic, cysteine-rich (SPARC), and glutamate receptor (GR1A1) genes. This 5q- syndrome critical region is telomeric to and distinct from the other critical regions on 5q associated with MDS and acute myeloid leukaemia.
29
Proposals for the classification of the myelodysplastic syndromes
John M. Bennett, Daniel Catovsky, MT Daniel et al. · British Journal of Haematology · 1982 · 3.7K citations
Medicine, Hematology, Pathology +12
Michelle M. Le Beau, Kathy S. Albain, Richard A. Larson et al. · Journal of Clinical Oncology · 1986 · 686 citations
Medicine, Hematology, Oncology +17
Distinct haematological disorder with deletion of long arm of No. 5 chromosome
Herman Van den Berghe, Jean‐Jacques Cassiman, Guido David et al. · Nature · 1974 · 442 citations
Life Sciences, Genetics, Hematology +14
T. Kayano, Charles Burant, Hirofumi Fukumoto et al. · Journal of Biological Chemistry · 1990 · 389 citations · Full text